Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?-Reference-Cited by-同舟云学术

Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?

Published:2018-05-07 Issue:1 Volume:22 Page:143-149
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Bozkaya Yakup¹,Özdemir Nuriye Yıldırım¹,Sezer Sevilay²,Köstek Osman³,Demirci Nebi Serkan¹,Yazıcı Ozan¹,Erdem Gökmen Umut¹,Eren Tülay¹,Zengin Nurullah¹

Affiliation:

1. Department of Medical Oncology, SBÜ Ankara Numune Education and Research Hospital, Ankara, Turkey

2. Department of Biochemistry, SBÜ Ankara Numune Education and Research Hospital, Ankara, Turkey

3. Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference34 articles.

1. Cancer of the stomach;Pisters;DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology, 8th edn,2011

2. Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study;Ozdemir;Cancer Chemotherapy and Pharmacology,2014

3. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma;Ambrosini;Nat Med,1997

4. IAP family proteins–suppressors of apoptosis;Deveraux;Genes Dev,1999

5. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis;Lee;Eur J Gastroenterol Hepatol,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in neoadjuvant therapy for gastric cancer (Review);Oncology Letters;2022-04-13

2. Biomarker evaluation in radically resectable locally advanced gastric cancer treated with neoadjuvant chemotherapy: an evidence reappraisal;Therapeutic Advances in Medical Oncology;2021-01

3. Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges;Chronic Diseases and Translational Medicine;2020-09

4. Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma;Cancers;2020-07-30

5. SPAG5 contributes to the progression of gastric cancer by upregulation of Survivin depend on activating the wnt/β-catenin pathway;Experimental Cell Research;2019-06